These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16931668)

  • 1. The efficacy of intratracheal administration of vecuronium in rats, compared with intravenous and intramuscular administration.
    Sunaga H; Kaneko M; Amaki Y
    Anesth Analg; 2006 Sep; 103(3):601-7. PubMed ID: 16931668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of the differences in the time to onset of action between rocuronium and vecuronium.
    Nava-Ocampo AA; Velázquez-Armenta Y; Moyao-García D; Salmerón J
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):125-30. PubMed ID: 16445711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacodynamics of vecuronium in chronic renal failure patients: the impact of different priming doses.
    Tarbeeh GA; Othman MM
    Ren Fail; 2012; 34(7):827-33. PubMed ID: 22607043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic comparison of prostaglandin E1 administered by different routes to rats.
    Gu FG; Cui FD; Gao YL
    Yao Xue Xue Bao; 2007 Jul; 42(7):787-93. PubMed ID: 17882966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of the dose-response and recovery time course of vecuronium and atracurium in anesthetized chinese adult patients.
    Xue FS; Li P; Liao X; Li CW; Xu YC; Liu Y; Liu KP; Sun HT
    Acta Anaesthesiol Taiwan; 2007 Mar; 45(1):9-14. PubMed ID: 17424753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sedation after intubation using etomidate and a long-acting neuromuscular blocker.
    Kendrick DB; Monroe KW; Bernard DW; Tofil NM
    Pediatr Emerg Care; 2009 Jun; 25(6):393-6. PubMed ID: 19458564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of smoking on dose requirements for vecuronium.
    Teiriä H; Rautoma P; Yli-Hankala A
    Br J Anaesth; 1996 Jan; 76(1):154-5. PubMed ID: 8672359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of body fat on the onset of vecuronium induced neuromuscular blockade.
    Takaya T; Takeyama K; Miura M; Takiguchi M
    Tokai J Exp Clin Med; 2001 Oct; 26(3):107-11. PubMed ID: 11885752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of rapacuronium in infants and children with intravenous and intramuscular administration.
    Reynolds LM; Infosino A; Brown R; Hsu J; Fisher DM
    Anesthesiology; 2000 Feb; 92(2):376-86. PubMed ID: 10691223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapacuronium: clinical pharmacology.
    Mirakhur RK; McCourt KC
    Eur J Anaesthesiol Suppl; 2001; 23():77-82. PubMed ID: 11766252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular, intravenous and oral levetiracetam in dogs: safety and pharmacokinetics.
    Patterson EE; Goel V; Cloyd JC; O'Brien TD; Fisher JE; Dunn AW; Leppik IE
    J Vet Pharmacol Ther; 2008 Jun; 31(3):253-8. PubMed ID: 18471147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of acute moderate isovolumic hemodilution on the pharmacokinetics of vecuronium].
    Xue F; Liu Q; Zou Q; An G; Luo L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Dec; 19(6):456-60. PubMed ID: 10453539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnesium sulphate as an adjuvant to total intravenous anesthesia in septorhinoplasty: a randomized controlled study.
    Cizmeci P; Ozkose Z
    Aesthetic Plast Surg; 2007; 31(2):167-73. PubMed ID: 17437152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onset of vecuronium-induced neuromuscular block after a long priming interval.
    Saitoh Y; Kaneda K; Murakawa M
    J Anesth; 2002; 16(2):102-7. PubMed ID: 14517658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacodynamic basis for the peak effect of vecuronium: peak twitch versus peak tetanic fade.
    Tripathi M; Tripathi M
    J Indian Med Assoc; 2002 Aug; 100(8):491-2, 494, 501. PubMed ID: 12675179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective doses of vecuronium in a patient with myotonic dystrophy.
    Nishi M; Itoh H; Tsubokawa T; Taniguchi T; Yamamoto K
    Anaesthesia; 2004 Dec; 59(12):1216-8. PubMed ID: 15549982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bolus injection of 20 ml saline with arm elevation on the onset time of vecuronium administered via a peripheral vein: a randomised controlled trial.
    Nitahara K; Sugi Y; Shigematsu K; Kusumoto G; Abe S; Higa K
    Anaesthesia; 2013 Sep; 68(9):904-7. PubMed ID: 23789813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of the non-depolarizing myorelaxant vecuronium bromide (norkuron) in children].
    Agavelian EG; Shaginian AK; Shabanova SK
    Anesteziol Reanimatol; 2007; (1):27-9. PubMed ID: 17460985
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative study of pharmacokinetics and pharmacodynamics of vecuronium in children and adults.
    Xue F; Liu Q; Zou Q; Luo L
    Chin Med J (Engl); 1998 Jan; 111(1):84-5. PubMed ID: 10322663
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacodynamics and pharmacokinetics of recombinant hirudin via four non-parenteral routes.
    Liu Y; Lu WL; Zhang X; Wang XQ; Zhang H; Zhang Q
    Peptides; 2005 Mar; 26(3):423-30. PubMed ID: 15652649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.